Pune Based Genova News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The milder Omicron variant raises hope that we can perhaps tame the pandemic. It is the unvaccinated who may usher in a fresh wave - Issue Date: Mar 14, 2022

What we know about India's new Covid vaccines - Covovax and Corbevax?

What we know about India's new Covid vaccines - Covovax and Corbevax?

Express News Service BENGALURU: While it is expected that the country will face a third wave by September, the chairman of National Technical Advisory Group on Immunisation (NTAGI), Dr Narendra Kumar Arora, has said that India can expect at least six more vaccines to be available by then. Of the six vaccines in the pipeline is the world’s first DNA-plasmid vaccine by Zydus-Cadilla, which is made in India. The Health Ministry expects to procure 30-35 crore doses by July to enable vaccinating one crore people a day. In a statement released to the media, from excerpts of an interview to Depar...

What we know about India's coronavirus vaccines Sun Online Desk   India's Covaxin, the homegrown government-backed vaccine, has an efficacy rate of 81%, preliminary data from its phase 3 trial shows. India's regulators gave the vaccine an emergency approval in January while the third phase of the trial was still under way, sparking scepticism and questions from experts. Bharat Biotech, the vaccine's manufacturer, said the latest findings were "an important milestone in vaccine discovery, for science and our fight against coronavirus". "With today's results from our phase 3 clinical trials, w...